Gregory Glenn | President, Research And Development
Novavax

Gregory Glenn, President, Research And Development, Novavax

Appearances:



Day 2, April 8 @ 09:10

Ph3 and beyond: Maternal RSV & older adult influenza vaccine programs

Gregory Glenn, President, Research And Development, Novavax

Day 2, April 8 @ 12:40

Recombinant nanoparticle COVID-19 vaccine: Platform technology for EID

Gregory Glenn, President, Research And Development, Novavax
last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates